SciStories LLC
@TeamSciStories
Followers
498
Following
2K
Media
84
Statuses
449
🔬 Effective communications for bioscience 🌟 Amplifying research 🚀 #ScienceCommunications #WomanOwned
Massachusetts, USA
Joined November 2018
Like you, we ❤️ #Science 🔬. We also specialize in #Marketing 🎯 (so you don't have to!🙅♀️). Get in touch and discover why we're the top #SciComms partner for over 100 scientists! https://t.co/A2KjuZY9st
0
0
0
🧬 🔬PPARβ/δ-orchestrated metabolic reprogramming supports the formation and maintenance of memory CD8+ T cells, via @SciImmunology. #TCellBiology #Immunology #AdaptiveImmunity
https://t.co/YkGa9NHQI6
science.org
A PPARβ/δ-mediated metabolic switch supports CD8+ T cells to form central memory and progenitor exhausted CD8+ T cells.
0
0
0
🧬@yasemin_sap describes ribbon diagrams as the iconic face of proteins, blending clarity & beauty in scientific representation. “It’s hard to imagine a more meaningful depiction,” Philip Bourne, UVA. @QuantaMagazine
https://t.co/wK3NsZcYYh
#ScientificVisualization
quantamagazine.org
Proteins are often visualized as cascades of curled ribbons and twisted strings, which both reveal and conceal the mess of atoms that make up these impossibly complex molecules.
0
0
1
🧬🔬Salmonella disrupts gut colonization resistance by depleting glucose, lowering acetate/butyrate, and increasing gut oxygenation—altering the host environment before microbiota changes. Via @cellcellpress #Microbiota #InfectiousDisease #GutHealth
https://t.co/fkozJsXzCB
cell.com
Rogers et al. show that Salmonella overcomes colonization resistance when the microbiota is compositionally intact by disrupting epithelial hypoxia. Pathogen outgrowth is fueled by catabolizing...
0
0
0
🧬Researchers at the University of Pittsburgh are using mRNA technology to revive damaged organs, potentially an alternative to transplants. 👀Clinical trials begin next year. @EmilyLMullin @Wired #mRNA #OrganTransplants
wired.com
Researchers are testing the use of mRNA to get damaged livers to repair themselves, in a move that could one day lessen the need for organ transplants.
0
1
1
In her latest @Nature story, @marilenharo highlights the challenges in testing medical AI tools. Many algorithms are approved with limited trials, sparking debate on proper validation. 👀 #AIinHealthcare #ClinicalTrials #PatientSafety
nature.com
Nature - Hundreds of medical algorithms have been approved on basis of limited clinical data. Scientists are debating who should test these tools and how best to do it.
0
0
0
👀Research published on @CDDPress shows that KHSRP plays a protective role in acute liver failure (ALF) by regulating pre-mRNA splicing. Targeting KHSRP could offer a new therapeutic approach for ALF. https://t.co/B7giq9BgU2
#LiverHealth #ALF #MedicalResearch
0
0
0
🔥🔥The World Health Organization has launched a global plan to stop mpox outbreaks, requiring $135M for coordinated efforts. Focus: surveillance, vaccination, research, and community empowerment. #mpox #GlobalHealth #WHO
https://t.co/VqwdRRKvil
0
0
0
🧬🔥A lung cancer patient at UCLH is the first to receive BioNTech's mRNA vaccine (BNT116) in a global trial. According to @Inside_PM, this groundbreaking treatment could revolutionize cancer care. Read here: https://t.co/fi7kwhnJ23
#CancerResearch #mRNA #Immunotherapy
insideprecisionmedicine.com
A Phase I clinical trial of mRNA-based lung cancer vaccine BNT116 has launched in 34 research sites in seven countries: the U.K., U.S., Germany, Hungary, Poland, Spain, and Turkey.
0
0
1
🔬Introducing biVI: a tool combining variational autoencoders with biophysical models to explore RNA transcription and splicing kinetics in single-cell RNA sequencing. Via @Nature: https://t.co/Rb3uCHik6N
#RNAseq #MachineLearning #Bioinformatics
nature.com
Nature Methods - biVI models the biophysical processes generating nascent and mature single-cell transcriptomes using variational autoencoders.
0
0
0
🧬Chun-Yu Chen, PhD, on addressing Hemophilia A with CRISPR/Cas9 mRNA LNP gene editing: https://t.co/aNcOEA8sPH via @genetherapylive #Hemophilia #GeneTherapy #CRISPRScience
cgtlive.com
The research scientist at Seattle Children’s Research Institute discussed findings from mouse research he presented at ASGCT’s 2024 conference.
0
0
0
🧬🔥@NatureComms introduces “Ribo-FilterOut” and “Ribo-Calibration”—new methods to improve ribosome profiling, accurately measuring ribosome numbers and translation rates across the genome. Learn more: https://t.co/yfqPpoJDqf
#Genomics #ProteinSynthesis #MolecularBiology
nature.com
Nature Communications - Ribosome profiling faces issues with rRNA contamination and measurements of ribosome numbers on transcripts. Here, the authors develop Ribo-FilterOut and Ribo-Calibration,...
0
0
2
👀Introducing the "LOOP" platform: a new inhaled mRNA therapy that shows promise in fighting pulmonary fibrosis by enhancing lung-specific delivery and expression via @Nature. Read more: https://t.co/T8PbvuId3K
#mRNA #nanotechnology #pulmonaryfibrosis
0
0
1
🔬@TwoStepTx's tumor-targeting PIP technology enhances precision & safety in cancer treatment by delivering diverse payloads to solid tumors, overcoming single-target limitations. Website by @SciStories. #CancerResearch #TargetedTherapy #OncologyInnovation
https://t.co/HGld08FUb0
0
0
1
🧬@CaymanChemical reports GLP-1, GIP, and glucagon receptor agonists, initially for T2D, are now being explored for obesity, heart failure, and neurodegenerative conditions like Alzheimer's. #ObesityResearch #MedicalInnovation #Neuroscience Read more:
caymanchem.com
Originally developed to treat type 2 diabetes (T2D), glucagon-like peptide 1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptor agonists have found new therapeutic...
0
0
0
Hey follow researchers. We are a team from Berkeley and UCSD. We build a tool to help ourself to stay up to date with research trends. hope you will find it useful. check it out: https://t.co/g0fpbbagLt
2
3
23
Thank you @rohan_palanki, @hannahyamagata and @MJMitchell_Lab for the wonderful preview of our recent study published in @CellCellPress. Be sure to check out the paper: https://t.co/RdpFsspv2H
0
6
15
💥According to @FiercePharma, @Moderna_tx is partnering with @Coursera to offer a free course on mRNA technology, empowering global learners to explore its potential in medicine. #mRNA #STEMEducation #MedicalInnovation Learn more:
fiercepharma.com
With analysts estimating that millions of jobs in the STEM fields are currently going unfilled in the U.S., Moderna is doing its part to strengthen the workforce and close that gap. | With analysts...
0
1
0
🥳 🎉@TheDohertyInst recently announced @CvandeSandt awarded $1.6M NHMRC grant to study T-cell immunity & develop new vaccines for high-risk populations, focusing on viral immunity across the lifespan. Congratulations! #Immunology #MedicalResearch #NHMRC
https://t.co/R7WlJU9IXV
doherty.edu.au
1
1
7
Kudos to @kldavislab on launching their new site! They research treatment resistance in childhood cancer. @teamscistories designed the logo, created the illustrations, and designed the site. #CancerResearch #ScienceIllustration
https://t.co/XpXDqmGC3j
0
0
0
🔬As reported in @Nature, proximity sequencing detects mRNA, extracellular proteins, and protein complexes in single cells. This protocol guides probe creation, sequencing, and analysis in 16 hours. #CellBiology #SingleCellSequencing #MolecularResearch
https://t.co/T8PbvuHFec
0
0
0